rs3790993

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004369.4(COL6A3):​c.6855G>C​(p.Gly2285Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.538 in 1,613,458 control chromosomes in the GnomAD database, including 235,064 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 23792 hom., cov: 31)
Exomes 𝑓: 0.54 ( 211272 hom. )

Consequence

COL6A3
NM_004369.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 0.233
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-237350171-C-G is Benign according to our data. Variant chr2-237350171-C-G is described in ClinVar as [Benign]. Clinvar id is 94968.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-237350171-C-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.233 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.645 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A3NM_004369.4 linkc.6855G>C p.Gly2285Gly synonymous_variant Exon 28 of 44 ENST00000295550.9 NP_004360.2 P12111-1D9ZGF2Q8N4Z1Q63HQ4
COL6A3NM_057167.4 linkc.6237G>C p.Gly2079Gly synonymous_variant Exon 27 of 43 NP_476508.2 P12111-2Q8N4Z1Q63HQ4
COL6A3NM_057166.5 linkc.5034G>C p.Gly1678Gly synonymous_variant Exon 25 of 41 NP_476507.3 P12111-4B7ZW00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A3ENST00000295550.9 linkc.6855G>C p.Gly2285Gly synonymous_variant Exon 28 of 44 1 NM_004369.4 ENSP00000295550.4 P12111-1
COL6A3ENST00000472056.5 linkc.5034G>C p.Gly1678Gly synonymous_variant Exon 25 of 41 1 ENSP00000418285.1 P12111-4
COL6A3ENST00000353578.9 linkc.6237G>C p.Gly2079Gly synonymous_variant Exon 27 of 43 5 ENSP00000315873.4 P12111-2
COL6A3ENST00000491769.1 linkn.1109G>C non_coding_transcript_exon_variant Exon 5 of 20 5

Frequencies

GnomAD3 genomes
AF:
0.556
AC:
84468
AN:
151800
Hom.:
23760
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.586
Gnomad AMI
AF:
0.645
Gnomad AMR
AF:
0.503
Gnomad ASJ
AF:
0.581
Gnomad EAS
AF:
0.664
Gnomad SAS
AF:
0.514
Gnomad FIN
AF:
0.594
Gnomad MID
AF:
0.573
Gnomad NFE
AF:
0.537
Gnomad OTH
AF:
0.556
GnomAD3 exomes
AF:
0.542
AC:
136333
AN:
251332
Hom.:
37415
AF XY:
0.543
AC XY:
73756
AN XY:
135844
show subpopulations
Gnomad AFR exome
AF:
0.581
Gnomad AMR exome
AF:
0.460
Gnomad ASJ exome
AF:
0.576
Gnomad EAS exome
AF:
0.654
Gnomad SAS exome
AF:
0.513
Gnomad FIN exome
AF:
0.586
Gnomad NFE exome
AF:
0.540
Gnomad OTH exome
AF:
0.560
GnomAD4 exome
AF:
0.536
AC:
783904
AN:
1461540
Hom.:
211272
Cov.:
51
AF XY:
0.536
AC XY:
389581
AN XY:
727108
show subpopulations
Gnomad4 AFR exome
AF:
0.584
Gnomad4 AMR exome
AF:
0.466
Gnomad4 ASJ exome
AF:
0.572
Gnomad4 EAS exome
AF:
0.672
Gnomad4 SAS exome
AF:
0.515
Gnomad4 FIN exome
AF:
0.583
Gnomad4 NFE exome
AF:
0.530
Gnomad4 OTH exome
AF:
0.556
GnomAD4 genome
AF:
0.557
AC:
84557
AN:
151918
Hom.:
23792
Cov.:
31
AF XY:
0.556
AC XY:
41296
AN XY:
74220
show subpopulations
Gnomad4 AFR
AF:
0.586
Gnomad4 AMR
AF:
0.503
Gnomad4 ASJ
AF:
0.581
Gnomad4 EAS
AF:
0.664
Gnomad4 SAS
AF:
0.515
Gnomad4 FIN
AF:
0.594
Gnomad4 NFE
AF:
0.537
Gnomad4 OTH
AF:
0.561
Alfa
AF:
0.515
Hom.:
5735
Bravo
AF:
0.552
Asia WGS
AF:
0.601
AC:
2091
AN:
3478
EpiCase
AF:
0.542
EpiControl
AF:
0.544

ClinVar

Significance: Benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:10
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 27, 2018
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 25, 2021
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 25, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 71% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 66. Only high quality variants are reported. -

Bethlem myopathy 1A Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dystonia 27 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Collagen 6-related myopathy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Ullrich congenital muscular dystrophy 1A Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
7.0
DANN
Benign
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3790993; hg19: chr2-238258814; COSMIC: COSV55078615; API